HAEMONETICS CORP/MASS (HAE)

US4050241003 - Common Stock

75.44  -1.46 (-1.9%)

After market: 75.44 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
993.2M
14.10%		1.169B
17.67%		1.309B
12.01%		1.408B
7.56%		1.456B
3.41%		1.586B
8.93%		1.832B
15.51%
EBITDA
YoY % growth
198.3M
25.59%		261.5M
31.87%		310.449M
18.72%		430.6M
38.70%		459.51M
6.71%		490.6M
6.77%		N/A
EBIT
YoY % growth
100.6M
36.68%		168.2M
67.20%		213.234M
26.77%		334.11M
56.69%		381.42M
14.16%		427.94M
12.20%		522.57M
22.11%
Operating Margin
10.13%14.39%16.29%23.73%26.20%26.98%28.52%
EPS
YoY % growth
2.59
10.21%		3.03
16.99%		3.98
31.35%		4.64
16.50%		5.34
15.07%		6.14
15.12%		7.63
24.16%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		1.19
14.11%		1.30
44.13%		1.20
17.56%		1.30
15.88%		1.38
16.03%		1.48
14.20%		1.38
14.76%		1.48
14.12%		1.63
18.06%		1.78
19.86%
Revenue
Q2Q % growth		357.49M
6.32%		362.65M
5.64%		352.83M
4.96%		361.78M
4.71%		372.35M
4.16%		378.96M
4.50%		374.46M
6.13%		389.08M
7.55%		404.86M
8.73%		406.5M
7.27%
EBITDA
Q2Q % growth		105.68M
-17.82%		111.33M
-20.00%		127.81M
48.90%		106.64M
-7.85%		118.29M
11.93%		123.64M
11.06%		N/AN/AN/AN/A
EBIT
Q2Q % growth		86.655M
46.81%		91.432M
117.99%		84.751M
49.47%		89.564M
56.11%		97.518M
12.54%		99.667M
9.01%		98.833M
16.62%		107.91M
20.48%		117.27M
20.25%		116.96M
17.35%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth		 1.12
13.13%		1.080.043.35%
Q1 2025
Q2Q % growth		 1.02
-2.86%		1.020.000.44%
Q4 2024
Q2Q % growth		 0.90
16.88%		0.900.00-0.02%
Q3 2024
Q2Q % growth		 1.04
22.35%		0.950.099.38%
Q2 2024
Q2Q % growth		 0.99
19.28%		0.900.0910.37%
Q1 2024
Q2Q % growth		 1.05
81.03%		0.740.3142.31%
Q4 2023
Q2Q % growth		 0.77
18.46%		0.710.068.16%
Q3 2023
Q2Q % growth		 0.85
1.19%		0.810.044.81%
Q2 2023
Q2Q % growth		 0.83
38.33%		0.680.1521.95%
Q1 2023
Q2Q % growth		 0.58
16.00%		0.520.0612.50%
Q4 2022
Q2Q % growth		 0.65
41.30%		0.610.047.16%
Q3 2022
Q2Q % growth		 0.84
3.70%		0.740.1013.25%
Q2 2022
Q2Q % growth		 0.60
-3.23%		0.61-0.01-1.99%
Q1 2022
Q2Q % growth		 0.50
8.70%		0.450.0510.01%
Q4 2021
Q2Q % growth		 0.46
-33.33%		0.68-0.22-32.20%
Q3 2021
Q2Q % growth		 0.81
-13.83%		0.660.1522.57%
Q2 2021
Q2Q % growth		 0.62
-28.74%		0.510.1121.42%
Q1 2021
Q2Q % growth		 0.46
-43.21%		0.420.0410.09%
Q4 2020
Q2Q % growth		 0.69
13.11%		0.74-0.05-6.36%
Q3 2020
Q2Q % growth		 0.94
49.21%		0.770.1722.83%
Q2 2020
Q2Q % growth		 0.87
55.36%		0.700.1723.99%
Q1 2020
Q2Q % growth		 0.81
37.29%		0.640.1726.44%
Q4 2019
Q2Q % growth		 0.61
41.86%		0.560.059.47%
Q3 2019
Q2Q % growth		 0.63
1.61%		0.600.035.47%
Q2 2019
Q2Q % growth		 0.56
16.67%		0.550.012.41%
Q1 2019
Q2Q % growth		 0.59
78.79%		0.420.1740.76%
Q4 2018
Q2Q % growth		 0.43 0.430.000.47%
Q3 2018
Q2Q % growth		 0.62 0.440.1840.89%
Q2 2018
Q2Q % growth		 0.48 0.410.0716.27%
Q1 2018
Q2Q % growth		 0.33 0.320.014.14%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth		 345.511M
8.59%		346.07M-559K-0.16%
Q1 2025
Q2Q % growth		 336.172M
7.98%		338.73M-2.558M-0.76%
Q4 2024
Q2Q % growth		 343.29M
12.77%		332.4M10.89M3.28%
Q3 2024
Q2Q % growth		 336.25M
10.14%		323.5M12.75M3.94%
Q2 2024
Q2Q % growth		 318.183M
6.95%		316.25M1.933M0.61%
Q1 2024
Q2Q % growth		 311.332M
19.06%		295.62M15.712M5.31%
Q4 2023
Q2Q % growth		 304.416M
14.87%		292.54M11.876M4.06%
Q3 2023
Q2Q % growth		 305.3M
17.51%		303.47M1.83M0.60%
Q2 2023
Q2Q % growth		 297.5M
24.01%		271.91M25.59M9.41%
Q1 2023
Q2Q % growth		 261.5M
14.44%		251.49M10.01M3.98%
Q4 2022
Q2Q % growth		 265M
17.78%		259.03M5.97M2.30%
Q3 2022
Q2Q % growth		 259.8M
8.07%		269.41M-9.61M-3.57%
Q2 2022
Q2Q % growth		 239.9M
14.51%		243.82M-3.92M-1.61%
Q1 2022
Q2Q % growth		 228.5M
16.82%		221.55M6.95M3.14%
Q4 2021
Q2Q % growth		 225M
-5.66%		225.21M-210K-0.09%
Q3 2021
Q2Q % growth		 240.4M
-7.18%		226.53M13.87M6.12%
Q2 2021
Q2Q % growth		 209.5M
-17.06%		209.73M-230K-0.11%
Q1 2021
Q2Q % growth		 195.6M
-17.99%		200.26M-4.66M-2.33%
Q4 2020
Q2Q % growth		 238.5M
-4.33%		249M-10.5M-4.22%
Q3 2020
Q2Q % growth		 259M
4.69%		257.96M1.04M0.40%
Q2 2020
Q2Q % growth		 252.6M
4.55%		252.27M330K0.13%
Q1 2020
Q2Q % growth		 238.5M
4.01%		240.09M-1.59M-0.66%
Q4 2019
Q2Q % growth		 249.3M
6.72%		253.14M-3.84M-1.52%
Q3 2019
Q2Q % growth		 247.4M
5.73%		252.63M-5.23M-2.07%
Q2 2019
Q2Q % growth		 241.6M
7.19%		235.78M5.82M2.47%
Q1 2019
Q2Q % growth		 229.3M
8.67%		222.15M7.15M3.22%
Q4 2018
Q2Q % growth		 233.6M 229.39M4.21M1.84%
Q3 2018
Q2Q % growth		 234M 229.93M4.07M1.77%
Q2 2018
Q2Q % growth		 225.4M 221.45M3.95M1.78%
Q1 2018
Q2Q % growth		 211M 214.24M-3.24M-1.51%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -4.59% 0.04% -0.36%
Revenue0% -1.37% -0.14% -0.14%